Table of Content

1 Liposomal Amphoteracin B Market Overview
1.1 Product Overview and Scope of Liposomal Amphoteracin B
1.2 Liposomal Amphoteracin B Segment by Type
1.2.1 Global Liposomal Amphoteracin B Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 25mg
1.2.3 50mg
1.3 Liposomal Amphoteracin B Segment by Application
1.3.1 Liposomal Amphoteracin B Sales Comparison by Application: (2021-2027)
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Global Liposomal Amphoteracin B Market Size Estimates and Forecasts
1.4.1 Global Liposomal Amphoteracin B Revenue 2016-2027
1.4.2 Global Liposomal Amphoteracin B Sales 2016-2027
1.4.3 Liposomal Amphoteracin B Market Size by Region: 2016 Versus 2021 Versus 2027

2 Liposomal Amphoteracin B Market Competition by Manufacturers
2.1 Global Liposomal Amphoteracin B Sales Market Share by Manufacturers (2016-2021)
2.2 Global Liposomal Amphoteracin B Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Liposomal Amphoteracin B Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Liposomal Amphoteracin B Manufacturing Sites, Area Served, Product Type
2.5 Liposomal Amphoteracin B Market Competitive Situation and Trends
2.5.1 Liposomal Amphoteracin B Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Liposomal Amphoteracin B Players Market Share by Revenue
2.5.3 Global Liposomal Amphoteracin B Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Liposomal Amphoteracin B Retrospective Market Scenario by Region
3.1 Global Liposomal Amphoteracin B Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Liposomal Amphoteracin B Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Liposomal Amphoteracin B Market Facts & Figures by Country
3.3.1 North America Liposomal Amphoteracin B Sales by Country
3.3.2 North America Liposomal Amphoteracin B Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Liposomal Amphoteracin B Market Facts & Figures by Country
3.4.1 Europe Liposomal Amphoteracin B Sales by Country
3.4.2 Europe Liposomal Amphoteracin B Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Liposomal Amphoteracin B Market Facts & Figures by Region
3.5.1 Asia Pacific Liposomal Amphoteracin B Sales by Region
3.5.2 Asia Pacific Liposomal Amphoteracin B Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Liposomal Amphoteracin B Market Facts & Figures by Country
3.6.1 Latin America Liposomal Amphoteracin B Sales by Country
3.6.2 Latin America Liposomal Amphoteracin B Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Liposomal Amphoteracin B Market Facts & Figures by Country
3.7.1 Middle East and Africa Liposomal Amphoteracin B Sales by Country
3.7.2 Middle East and Africa Liposomal Amphoteracin B Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Liposomal Amphoteracin B Historic Market Analysis by Type
4.1 Global Liposomal Amphoteracin B Sales Market Share by Type (2016-2021)
4.2 Global Liposomal Amphoteracin B Revenue Market Share by Type (2016-2021)
4.3 Global Liposomal Amphoteracin B Price by Type (2016-2021)

5 Global Liposomal Amphoteracin B Historic Market Analysis by Application
5.1 Global Liposomal Amphoteracin B Sales Market Share by Application (2016-2021)
5.2 Global Liposomal Amphoteracin B Revenue Market Share by Application (2016-2021)
5.3 Global Liposomal Amphoteracin B Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Gilead Sciences
6.1.1 Gilead Sciences Corporation Information
6.1.2 Gilead Sciences Description and Business Overview
6.1.3 Gilead Sciences Liposomal Amphoteracin B Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Gilead Sciences Product Portfolio
6.1.5 Gilead Sciences Recent Developments/Updates
6.2 Cipla
6.2.1 Cipla Corporation Information
6.2.2 Cipla Description and Business Overview
6.2.3 Cipla Liposomal Amphoteracin B Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Cipla Product Portfolio
6.2.5 Cipla Recent Developments/Updates

7 Liposomal Amphoteracin B Manufacturing Cost Analysis
7.1 Liposomal Amphoteracin B Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Liposomal Amphoteracin B
7.4 Liposomal Amphoteracin B Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Liposomal Amphoteracin B Distributors List
8.3 Liposomal Amphoteracin B Customers

9 Liposomal Amphoteracin B Market Dynamics
9.1 Liposomal Amphoteracin B Industry Trends
9.2 Liposomal Amphoteracin B Growth Drivers
9.3 Liposomal Amphoteracin B Market Challenges
9.4 Liposomal Amphoteracin B Market Restraints

10 Global Market Forecast
10.1 Liposomal Amphoteracin B Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Liposomal Amphoteracin B by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Liposomal Amphoteracin B by Type (2022-2027)
10.2 Liposomal Amphoteracin B Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Liposomal Amphoteracin B by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Liposomal Amphoteracin B by Application (2022-2027)
10.3 Liposomal Amphoteracin B Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Liposomal Amphoteracin B by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Liposomal Amphoteracin B by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Liposomal Amphoteracin B Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Liposomal Amphoteracin B Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Liposomal Amphoteracin B Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Liposomal Amphoteracin B Covered in This Study
Table 5. Global Liposomal Amphoteracin B Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Liposomal Amphoteracin B Sales Share by Manufacturers (2016-2021)
Table 7. Global Liposomal Amphoteracin B Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Liposomal Amphoteracin B Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Liposomal Amphoteracin B Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Liposomal Amphoteracin B Manufacturing Sites and Area Served
Table 11. Manufacturers Liposomal Amphoteracin B Product Type
Table 12. Global Liposomal Amphoteracin B Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Liposomal Amphoteracin B by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liposomal Amphoteracin B as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Liposomal Amphoteracin B Sales by Region (2016-2021) & (K Units)
Table 16. Global Liposomal Amphoteracin B Sales Market Share by Region (2016-2021)
Table 17. Global Liposomal Amphoteracin B Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Liposomal Amphoteracin B Sales by Country (2016-2021) & (K Units)
Table 19. North America Liposomal Amphoteracin B Sales Market Share by Country (2016-2021)
Table 20. North America Liposomal Amphoteracin B Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Liposomal Amphoteracin B Revenue Market Share by Country (2016-2021)
Table 22. Europe Liposomal Amphoteracin B Sales by Country (2016-2021) & (K Units)
Table 23. Europe Liposomal Amphoteracin B Sales Market Share by Country (2016-2021)
Table 24. Europe Liposomal Amphoteracin B Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Liposomal Amphoteracin B Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Liposomal Amphoteracin B Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Liposomal Amphoteracin B Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Liposomal Amphoteracin B Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Liposomal Amphoteracin B Revenue Market Share by Region (2016-2021)
Table 30. Latin America Liposomal Amphoteracin B Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Liposomal Amphoteracin B Sales Market Share by Country (2016-2021)
Table 32. Latin America Liposomal Amphoteracin B Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Liposomal Amphoteracin B Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Liposomal Amphoteracin B Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Liposomal Amphoteracin B Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Liposomal Amphoteracin B Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Liposomal Amphoteracin B Revenue Market Share by Country (2016-2021)
Table 38. Global Liposomal Amphoteracin B Sales (K Units) by Type (2016-2021)
Table 39. Global Liposomal Amphoteracin B Sales Market Share by Type (2016-2021)
Table 40. Global Liposomal Amphoteracin B Revenue (Million US$) by Type (2016-2021)
Table 41. Global Liposomal Amphoteracin B Revenue Share by Type (2016-2021)
Table 42. Global Liposomal Amphoteracin B Price (US$/Unit) by Type (2016-2021)
Table 43. Global Liposomal Amphoteracin B Sales (K Units) by Application (2016-2021)
Table 44. Global Liposomal Amphoteracin B Sales Market Share by Application (2016-2021)
Table 45. Global Liposomal Amphoteracin B Revenue (Million US$) by Application (2016-2021)
Table 46. Global Liposomal Amphoteracin B Revenue Share by Application (2016-2021)
Table 47. Global Liposomal Amphoteracin B Price (US$/Unit) by Application (2016-2021)
Table 48. Gilead Sciences Corporation Information
Table 49. Gilead Sciences Description and Business Overview
Table 50. Gilead Sciences Liposomal Amphoteracin B Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Gilead Sciences Liposomal Amphoteracin B Product
Table 52. Gilead Sciences Recent Developments/Updates
Table 53. Cipla Corporation Information
Table 54. Cipla Description and Business Overview
Table 55. Cipla Liposomal Amphoteracin B Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Cipla Liposomal Amphoteracin B Product
Table 57. Cipla Recent Developments/Updates
Table 58. Production Base and Market Concentration Rate of Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Liposomal Amphoteracin B Distributors List
Table 61. Liposomal Amphoteracin B Customers List
Table 62. Liposomal Amphoteracin B Market Trends
Table 63. Liposomal Amphoteracin B Growth Drivers
Table 64. Liposomal Amphoteracin B Market Restraints
Table 65. Global Liposomal Amphoteracin B Sales Forecast by Type (2022-2027) & (K Units)
Table 66. Global Liposomal Amphoteracin B Sales Market Share Forecast by Type (2022-2027)
Table 67. Global Liposomal Amphoteracin B Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 68. Global Liposomal Amphoteracin B Revenue Market Share Forecast by Type (2022-2027)
Table 69. Global Liposomal Amphoteracin B Sales Forecast by Application (2022-2027) & (K Units)
Table 70. Global Liposomal Amphoteracin B Sales Market Share Forecast by Application (2022-2027)
Table 71. Global Liposomal Amphoteracin B Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 72. Global Liposomal Amphoteracin B Revenue Market Share Forecast by Application (2022-2027)
Table 73. Global Liposomal Amphoteracin B Sales Forecast by Region (2022-2027) & (K Units)
Table 74. Global Liposomal Amphoteracin B Sales Market Share Forecast by Region (2022-2027)
Table 75. Global Liposomal Amphoteracin B Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 76. Global Liposomal Amphoteracin B Revenue Market Share Forecast by Region (2022-2027)
Table 77. Research Programs/Design for This Report
Table 78. Key Data Information from Secondary Sources
Table 79. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Liposomal Amphoteracin B
Figure 2. Global Liposomal Amphoteracin B Market Share by Type in 2020 & 2027
Figure 3. 25mg Product Picture
Figure 4. 50mg Product Picture
Figure 5. Global Liposomal Amphoteracin B Market Share by Application in 2020 & 2027
Figure 6. Hospital
Figure 7. Pharmacy
Figure 8. Global Liposomal Amphoteracin B Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Liposomal Amphoteracin B Market Size 2016-2027 (US$ Million)
Figure 10. Global Liposomal Amphoteracin B Sales 2016-2027 (K Units)
Figure 11. Global Liposomal Amphoteracin B Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 12. Liposomal Amphoteracin B Sales Share by Manufacturers in 2020
Figure 13. Global Liposomal Amphoteracin B Revenue Share by Manufacturers in 2020
Figure 14. The Global 5 and 10 Largest Liposomal Amphoteracin B Players: Market Share by Revenue in 2020
Figure 15. Liposomal Amphoteracin B Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 16. Global Liposomal Amphoteracin B Sales Market Share by Region (2016-2021)
Figure 17. Global Liposomal Amphoteracin B Sales Market Share by Region in 2020
Figure 18. Global Liposomal Amphoteracin B Revenue Market Share by Region (2016-2021)
Figure 19. Global Liposomal Amphoteracin B Revenue Market Share by Region in 2020
Figure 20. U.S. Liposomal Amphoteracin B Revenue Growth Rate (2016-2021) (US$ Million)
Figure 21. Canada Liposomal Amphoteracin B Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Germany Liposomal Amphoteracin B Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. France Liposomal Amphoteracin B Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. U.K. Liposomal Amphoteracin B Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Italy Liposomal Amphoteracin B Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Russia Liposomal Amphoteracin B Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. China Liposomal Amphoteracin B Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Japan Liposomal Amphoteracin B Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. South Korea Liposomal Amphoteracin B Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. India Liposomal Amphoteracin B Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Australia Liposomal Amphoteracin B Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Taiwan Liposomal Amphoteracin B Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Indonesia Liposomal Amphoteracin B Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Thailand Liposomal Amphoteracin B Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Malaysia Liposomal Amphoteracin B Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Philippines Liposomal Amphoteracin B Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Vietnam Liposomal Amphoteracin B Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Mexico Liposomal Amphoteracin B Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Brazil Liposomal Amphoteracin B Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Argentina Liposomal Amphoteracin B Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Turkey Liposomal Amphoteracin B Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Saudi Arabia Liposomal Amphoteracin B Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. UAE Liposomal Amphoteracin B Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Sales Market Share of Liposomal Amphoteracin B by Type (2016-2021)
Figure 45. Sales Market Share of Liposomal Amphoteracin B by Application (2016-2021)
Figure 46. Sales Market Share of Liposomal Amphoteracin B by Application in 2020
Figure 47. Revenue Share of Liposomal Amphoteracin B by Application (2016-2021)
Figure 48. Revenue Share of Liposomal Amphoteracin B by Application in 2020
Figure 49. Manufacturing Cost Structure of Liposomal Amphoteracin B
Figure 50. Manufacturing Process Analysis of Liposomal Amphoteracin B
Figure 51. Liposomal Amphoteracin B Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed